Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease...

Area of Science:

• Biochemistry
• Cardiology
• Nephrology

Background:

• Bilirubin, a known neonatal neurotoxin, exhibits protective effects in adults.
• Physiological serum bilirubin concentrations are linked to reduced risks of chronic kidney disease (CKD) and cardiovascular disease (CVD).

Purpose of the Study:

• To review the biological actions of bilirubin in the pathogenesis of CKD and CVD.
• To explore bilirubin metabolism as a therapeutic target for ameliorating morbidity and mortality in CKD patients.

Main Methods:

• Literature review of recent advances in bilirubin's biological actions.
• Analysis of bilirubin's role in vascular homeostasis, insulin sensitivity, and lipid metabolism.

Main Results:

• Bilirubin's antioxidant and anti-inflammatory properties are key to its protective mechanisms against CKD and CVD.
• Bilirubin improves insulin sensitivity, lowers LDL cholesterol, and inhibits platelet activation.
• These effects contribute to maintaining vascular homeostasis and reducing disease progression and mortality.

Conclusions:

• Targeting bilirubin metabolism presents a promising therapeutic strategy for CKD and CVD.
• Modulating bilirubin levels could mitigate the progression and complications of CKD and CVD.
• Further research into bilirubin's multifaceted roles is warranted for clinical applications.